Skip to main content
logo
Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
53.36
-1.78 (-3.23%)
At close: Jul 10, 2026, 4:00 PM EDT
53.39
+0.03 (0.06%)
After-hours: Jul 10, 2026, 6:29 PM EDT

Structure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
Net Income
-170.34-141.2-122.53-89.62-38.05-15.88
Depreciation & Amortization
1.641.330.990.30.07-
Stock-Based Compensation
34.7128.9918.798.191.490.57
Other Adjustments
-11.2-23.28-16.86-5.320.270.08
Changes in Accounts Payable
-0.894.773.31-0.861.91.02
Changes in Accrued Expenses
22.3721.517.7212.163.410.8
Changes in Other Operating Activities
-21.14-114.32-8.06-4.34-1.25-0.88
Operating Cash Flow
-154.74-222.2-116.64-79.49-32.16-14.28
Capital Expenditures
-4.48-3.61-1.29-2.17-1.21-0.02
Purchases of Investments
-1,079-547.38-702.52-417.36-4.21-21.13
Proceeds from Sale of Investments
631.79630.54344.9151.1823.28-
Other Investing Activities
-10.25----
Investing Cash Flow
-441.1889.8-358.91-268.3417.86-21.15
Issuance of Common Stock
5.11765.15517.06473.10.01-
Repurchase of Common Stock
-3.04-0.62----
Net Common Stock Issued (Repurchased)
2.08764.54517.06473.10.01-
Issuance of Preferred Stock
----103.3625.84
Net Preferred Stock Issued (Repurchased)
----103.3625.84
Other Financing Activities
--2.02-1.8-21.57-0.12-
Financing Cash Flow
759.97762.52515.26451.53103.2525.84
Net Cash Flow
164.05630.1139.72103.788.95-9.59
Free Cash Flow
-159.22-225.81-117.93-81.66-33.37-14.3
Free Cash Flow Per Share
-0.73-1.27-0.75-0.74-12.30-3.95
Levered Free Cash Flow
-129.87-231.52-119.86-84.53-40.84-15.11
Unlevered Free Cash Flow
-211.38-266.24-155.16-97.41-34.54-14.84
SEC Filings: 10-K · 10-Q